Skip to main content
. 2023 Sep 19;13(40):27801–27827. doi: 10.1039/d3ra05689a

Effect of compound 15 and sorafenib on HT-29.cell cycle progression.

Sample Cell cycle distribution (%)
% G0-G1 % S % G2/M
Compound 15/HT-29 58.26 ± 1.74 33.04 ± 2.22a 8.70 ± 0.6a
Sorafenib/HT-29 51.95 ± 1.05a,b 41.06 ± 1.49a,b 6.99 ± 1.01a,b
Control HT-29 61.44 ± 1.56 25.82 ± 0.62 12.74 ± 1.7
a

Significant P value from control HT-29.

b

Significant P value from compound 15/HT-29, significant P value <0.05 & by using One-way ANOVA followed by Tukey's post hoc multiple comparison tests.